Crowdfunding for Cancer Care: A Virtual Safety Net
Getting Your Ducks in a Row When Traveling During Cancer Treatment
March 06, 2017 – Marilyn Fenichel
Hitting a Nerve: Nerve Damage From Cancer Treatment Can Impair Sexual Function
March 07, 2017 – Mark Cantrell
Keeping Your Colorectal Cancer Screening Options Open
March 07, 2017 – Arlene Weintraub
The Skin You're In: Coping With Body Changes After Cancer
March 08, 2017 – Dara Chadwick
Comments From Our Readers- Winter 2017
March 09, 2017
When Less is More
March 06, 2017 – Mike Hennessy, Sr.
Snowbirds and Distance Medicine
March 06, 2017 – Debu Tripathy, MD
Currently Viewing
HPV Vaccine Series Abbreviated to Protect Against Cancer
March 09, 2017 – Beth Fand Incollingo
Developing Methods to Fight Cancer-Related Fatigue
March 09, 2017 – Christopher Pirschel
Can Cancer Be a Laughing Matter?
March 09, 2017 – Rajiv Samant, M.D.
Jim Kelly Kicks Off Cancer Awareness Program
March 10, 2017 – Allie Casey
Using Evolving Knowledge to Manage Cancer's Side Effects
March 10, 2017 – Len Lichtenfeld, M.D.
Understanding Cancer Treatment Customs
April 10, 2017 – Beth Fand Incollingo

HPV Vaccine Series Abbreviated to Protect Against Cancer

Now only two doses of the HPV vaccine are needed to protect children against a number of cancers. 
BY Beth Fand Incollingo
PUBLISHED March 09, 2017
ONLY TWO DOSES OF vaccine protecting against the human papillomavirus (HPV), rather than the previously recommended three, are needed to protect children against a host of cancers as they move into adulthood, according to a recent federal guideline.

The Centers for Disease Control and Prevention (CDC) set that guideline in October 2016, based on studies showing that two shots of the vaccine at least six months apart are equally or more effective than three injections for children under age 15. The CDC suggested that the reduced schedule would make it easier for parents and their children to comply, ultimately protecting more Americans against the cancers that can be caused by HPV.

However, teenagers and young adults who start the vaccine series when they are between the ages of 15 and 26, and people with weakened immune systems, should get three doses.

HPV can cause cervical, vulvar, vaginal, penile, anal, mouth and throat cancers. The virus is passed through sexual contact. Vaccines exist for seven types of HPV that, together, cause 73 percent of HPV-associated cancers; Gardasil 9 is the vaccine available in the United States. A recent study showed that Gardasil 9 could prevent 80 percent of cervical cancers in the U.S. if given to all children ages 11 and 12 prior to HPV exposure. Yet HPV-related cancers are on the rise, the CDC reports. One reason is that less than half of young people who are eligible are completing the series of vaccines.

The CDC recommends that all males and females should start the HPV vaccine series at the age of 11 or 12 years, but men can receive the series through age 21 and females through age 26.

“A certain level of cost and inconvenience is involved in requiring three separate doses, so any way we can lower that barrier without sacrificing protection is an improvement,” said Aimée Kreimer, Ph.D., of the National Cancer Institute’s Division of Cancer Epidemiology and Genomics. 
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles


Sign In

Not a member? Sign up now!

Sign Up

Are you a member? Please Log In